These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9539793)

  • 1. Bipolar localization of Bacillus subtilis topoisomerase IV, an enzyme required for chromosome segregation.
    Huang WM; Libbey JL; van der Hoeven P; Yu SX
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4652-7. PubMed ID: 9539793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA gyrase and DNA topoisomerase of Bacillus subtilis: expression and characterization of recombinant enzymes encoded by the gyrA, gyrB and parC, parE genes.
    Barnes MH; LaMarr WA; Foster KA
    Protein Expr Purif; 2003 Jun; 29(2):259-64. PubMed ID: 12767818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New topoisomerase essential for chromosome segregation in E. coli.
    Kato J; Nishimura Y; Imamura R; Niki H; Hiraga S; Suzuki H
    Cell; 1990 Oct; 63(2):393-404. PubMed ID: 2170028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Requirement of topoisomerase IV parC and parE genes for cell cycle progression and developmental regulation in Caulobacter crescentus.
    Ward D; Newton A
    Mol Microbiol; 1997 Dec; 26(5):897-910. PubMed ID: 9426128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and characterization of the parC and parE genes of Streptococcus pneumoniae encoding DNA topoisomerase IV: role in fluoroquinolone resistance.
    Pan XS; Fisher LM
    J Bacteriol; 1996 Jul; 178(14):4060-9. PubMed ID: 8763932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IV.
    Akasaka T; Onodera Y; Tanaka M; Sato K
    Antimicrob Agents Chemother; 1999 Mar; 43(3):530-6. PubMed ID: 10049263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential and dynamic localization of topoisomerases in Bacillus subtilis.
    Tadesse S; Graumann PL
    J Bacteriol; 2006 Apr; 188(8):3002-11. PubMed ID: 16585761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of DNA topoisomerase IV in Escherichia coli.
    Kato J; Suzuki H; Ikeda H
    J Biol Chem; 1992 Dec; 267(36):25676-84. PubMed ID: 1334483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escherichia coli topoisomerase IV. Purification, characterization, subunit structure, and subunit interactions.
    Peng H; Marians KJ
    J Biol Chem; 1993 Nov; 268(32):24481-90. PubMed ID: 8227000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolones inhibit preferentially Streptococcus pneumoniae DNA topoisomerase IV than DNA gyrase native proteins.
    Fernandez-Moreira E; Balas D; Gonzalez I; de la Campa AG
    Microb Drug Resist; 2000; 6(4):259-67. PubMed ID: 11272253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell cycle expression and transcriptional regulation of DNA topoisomerase IV genes in caulobacter.
    Ward DV; Newton A
    J Bacteriol; 1999 Jun; 181(11):3321-9. PubMed ID: 10348842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ParC subunit of DNA topoisomerase IV of Streptococcus pneumoniae is a primary target of fluoroquinolones and cooperates with DNA gyrase A subunit in forming resistance phenotype.
    Muñoz R; De La Campa AG
    Antimicrob Agents Chemother; 1996 Oct; 40(10):2252-7. PubMed ID: 8891124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical and functional interaction between the condensin MukB and the decatenase topoisomerase IV in Escherichia coli.
    Hayama R; Marians KJ
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18826-31. PubMed ID: 20696938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and nucleotide sequences of the topoisomerase IV parC and parE genes of Mycoplasma hominis.
    Bébéar CM; Charron A; Bové JM; Bébéar C; Renaudin J
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2024-31. PubMed ID: 9687401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ParE-ParC fusion protein is a functional topoisomerase.
    Lavasani LS; Hiasa H
    Biochemistry; 2001 Jul; 40(29):8438-43. PubMed ID: 11456480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topoisomerase IV can functionally replace all type 1A topoisomerases in Bacillus subtilis.
    Reuß DR; Faßhauer P; Mroch PJ; Ul-Haq I; Koo BM; Pöhlein A; Gross CA; Daniel R; Brantl S; Stülke J
    Nucleic Acids Res; 2019 Jun; 47(10):5231-5242. PubMed ID: 30957856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
    Pan XS; Yague G; Fisher LM
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of Escherichia coli topoisomerase IV. II. ATPase negative mutants of parE induce hyper-DNA cleavage.
    Nurse P; Bahng S; Mossessova E; Marians KJ
    J Biol Chem; 2000 Feb; 275(6):4104-11. PubMed ID: 10660570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and nucleotide sequence of the DNA gyrase (gyrA) gene from Mycoplasma hominis and characterization of quinolone-resistant mutants selected in vitro with trovafloxacin.
    Bébéar CM; Grau O; Charron A; Renaudin H; Gruson D; Bébéar C
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2719-27. PubMed ID: 10991851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and primary structure of Staphylococcus aureus DNA topoisomerase IV: a primary target of fluoroquinolones.
    Ferrero L; Cameron B; Manse B; Lagneaux D; Crouzet J; Famechon A; Blanche F
    Mol Microbiol; 1994 Aug; 13(4):641-53. PubMed ID: 7997176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.